|
1
|
Perez-Ordoñez B, Beauchemin M and Jordan
RC: Molecular biology of squamous cell carcinoma of the head and
neck. J Clin Pathol. 59:445–453. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Toh Y, Oki E, Ohgaki K, Sakamoto Y, Ito S,
Egashira A, Saeki H, Kakeji Y, Morita M, Sakaguchi Y, et al:
Alcohol drinking, cigarette smoking, and development of squamous
cell carcinoma of the esophagus: Molecular mechanisms of
carcinogenesis. Inc J Clin Oncol. 15:135–144. 2010. View Article : Google Scholar
|
|
3
|
Slaughter DP, Southwick HW and Smejkal W:
Field cancerization in oral stratified squamous epithelium;
clinical implications of multicentric origin. Cancer. 6:963–968.
1953. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ina H, Shibuya H, Ohashi I and Kitagawa M:
The frequency of a concomitant early esophageal cancer in male
patients with oral and oropharyngeal cancer. Screening results
using Lugol dye endoscopy. Cancer. 73:2038–2041. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dubuc J, Legoux J..Winnock M, Seyrig
J..Barbier J..Barrioz T, Laugier R, Boulay G, Grasset D, Sautereau
D, et al: Endoscopic screening for esophageal squamous cell
carcinoma in high-risk patients: A prospective study conducted in
62 French endoscopy centers. Endoscopy. 57:690–695. 2006.
View Article : Google Scholar
|
|
6
|
Goda K, Dobashi A and Tajiri H:
Perspectives on narrow-band imaging endoscopy for superficial
squamous neoplasms of the orohypopharynx and esophagus. Dig Endosc.
26 Suppl 1:S1–S11. 2014. View Article : Google Scholar
|
|
7
|
Shimizu Y, Yamamoto J, Kato M, Yoshida T,
Hirota J, Ono Y, Nakagawa M, Nakagawa S, Oridate N and Asaka M:
Endoscopic submucosal dissection for treatment of early stage
hypopharyngeal carcinoma. Gastrointest Endosc. 64:255–262. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hanaoka N, Ishihara R, Takeuchi Y, Suzuki
M, Otozai S, Kida K, Yoshii T, Fujii T, Yoshino K, Sugawa T, et al:
Endoscopic submucosal dissection as minimally invasive treatment
for superficial pharyngeal cancer: A phase II study (with video).
Gastrointest Endosc. 82:1002–1008. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mattijssen V, Peters HM, Schalkwijk L,
Manni JJ, van't Hof-Grootenboer B, de Mulder PH and Ruiter DJ:
E-cadherin expression in head and neck squamous-cell carcinoma is
associated with clinical outcome. Int J Cancer. 55:580–585. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu XC: Risk factors and gene expression in
esophageal cancer. Methods Mol Biol. 471:335–360. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Muramatsu M, Kinoshita K, Fagarasan S,
Yamada S, Shinkai Y and Honjo T: Class switch recombination and
hypermutation require activation-induced cytidine deaminase (AID),
a potential RNA editing enzyme. Cell. 102:553–563. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Matsumoto Y, Marusawa H, Kinoshita K, Endo
Y, Kou T, Morisawa T, Azuma T, Okazaki IM, Honjo T and Chiba T:
Helicobacter pylori infection triggers aberrant expression of
activation-induced cytidine deaminase in gastric epithelium. Nat
Med. 13:470–476. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hollestein M, Sidransky D, Vogelstein B
and Harris CC: p53 mutations in human cancers. Science. 253:49–53.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ohta M, Inoue H, Cotticelli MG, Kastury K,
Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, et al:
The FHIT gene, spanning the chromosome 3p14.2 fragile site and
renal carcinoma-associated t(3;8) breakpoint, is abnormal in
digestive tract cancer. Cell. 84:587–597. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mori M, Mimori K, Shiraishi T, Alder H,
Inoue H, Tanaka Y, Sugimachi K, Huebner K and Croce CM: Altered
expression of Fhit in carcinoma precarcinomatous lesions of the
esophagus. Cancer Res. 60:1177–1182. 2000.PubMed/NCBI
|
|
16
|
Lee EJ, Lee BB, Kim JW, Shim YM, Hoseok I,
Han J, Cho EY, Park J and Kim DH: Aberrant methylation of Fragile
Histidine Triad gene is associated with poor prognosis in early
stage esophageal squamous cell carcinoma. Eur J Cancer. 42:972–980.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Soma T, Kaganoi J, Kawabe A, Kondo K,
Imamura M and Shimada Y: Nicotine induces the fragile histidine
triad methylation in human esophageal squamous epithelial cells.
Int J Cancer. 119:1023–1027. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Morita M, Oyama T, Nakata S, Ono K, Sugaya
M, Uramoto H, Yoshimatsu T, Hanagiri T, Sugio K and Yasumoto K:
Expression of FHIT in esophageal epithelium and carcinoma:
Reference to drinking, smoking and multicentric carcinogenesis.
Anticancer Res. 26:2243–2248. 2006.PubMed/NCBI
|
|
19
|
Ishii H, Dumon KR, Vecchione A, Trapasso
F, Mimori K, Alder H, Mori M, Sozzi G, Baffa R, Huebner K and Croce
CM: Effect of adenoviral transduction of the fragile histidine
triad gene into esophageal cancer cells. Cancer Res. 61:1578–1584.
2001.PubMed/NCBI
|
|
20
|
Tamura S, Shiozaki H, Miyata M, Kadowaki
T, Inoue M, Matsui S, Iwazawa T, Takayama T, Takeichi M and Monden
M: Decreased E-cadherin expression is associated with haematogenous
recurrence and poor prognosis in patients with squamous cell
carcinoma of the oesophagus. Br J Surg. 83:1608–1614. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hirohashi S: Inactivation of the
E-cadherin-mediated cell adhesion system in human cancers. Am J
Pathol. 153:333–339. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Warren S and Gates O: Multiple primary,
malignant tumors: A survey of the literature and statistical study.
Am J Cancer. 16:1358–1414. 1932.
|
|
23
|
Brooks PJ, Enoch MA, Goldman D, Li TK and
Yokoyama A: The alcohol flushing response: An unrecognized risk
factor for esophageal cancer from alcohol consumption. PLoS Med.
6:e502009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Saldivar JC, Shibata H and Huebner K:
Pathology and biology associated with the fragile FHIT gene and
gene product. J Cell Biochem. 109:858–865. 2010.PubMed/NCBI
|
|
25
|
Yokoyama A, Mizukami T and Yokoyama T:
Genetic polymorphisms of alcohol dehydrogense-1B and aldehyde
dehydrogenase-2, alcohol flushing, mean corpuscular volume, and
aerodigestive tract neoplasia in Japanese drinkers. Adv Exp Med
Biol. 815:265–279. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sauter ER, Cleveland D, Trock B, Ridge JA
and Klein-Szanto AJ: p53 is overexpressed in fifty percent of
pre-invasive lesions of head and neck epithelium. Carcinogenesis.
15:2269–2274. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hayashi A, Yashima K, Takeda Y, Sasaki S,
Kawaguchi K, Harada K, Murawaki Y and Ito H: Fhit, E-cadherin, p53,
and activation-induced cytidine deaminase expression in
endoscopically resected early stage esophageal squamous neoplasia.
J Gastroenterol Hepatol. 27:1752–1758. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kohmura T, Hasegawa Y, Ogawa T, Matsuura
H, Takahashi M, Yanagita N and Nakashima T: Cyclin D1 and p53
overexpression predicts multiple primary malignant neoplasms of the
hypopharynx and esophagus. Arch Otolaryngol Head Neck Surg.
125:1351–1354. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kato H, Yoshikawa M, Miyazaki T, Nakajima
M, Fukai Y, Tajima K, Masuda N, Tsukada K, Fukuda T, Nakajima T and
Kuwano H: Expression of p53 protein related to smoking and
alcoholic beverage drinking habits in patients with esophageal
cancers. Cancer Lett. 167:65–72. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chung Y, Lam AK, Luk JM, Law S, Chan KW,
Lee PY and Wong J: Altered E-cadherin expression and p120 catenin
localization in esophageal squamous cell carcinoma. Ann Surg Oncol.
14:3260–3267. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Miyazaki Y, Fujinami M, Inoue H, Kikuchi
K, Ide F and Kusama K: Expression of activation-induced cytidine
deaminase in oral epithelial dysplasia and oral squamous cell
carcinoma. J Oral Sci. 55:293–299. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nakanishi Y, Kondo S, Wakisaka N, Tsuji A,
Endo K, Murono S, Ito M, Kitamura K, Muramatsu M and Yoshizaki T:
Role of activation-induced cytidine deaminase in the development of
oral squamous cell carcinoma. PLoS One. 8:e620662013. View Article : Google Scholar : PubMed/NCBI
|
